Şunu aradınız:: interkorporal (Danca - İngilizce)

lumbal interkorporal fusionskirurgi
lumbar interbody fusion surgery

1 observeret under brug ved lumbal interkorporal fusion
1 observed during use in lumbar interbody fusion

farmakodynamiske oplysninger specielt fra studier af interkorporal fusion:
pharmacodynamic information specific to lumbar interbody fusion studies

særlige advarsler og forsigtighedsregler vedrørende brugen specielt ved lumbal interkorporal fusion:
special warnings and precautions for use specific to lumbar interbody fusion

implanteret andre steder end lumbal rygsøjle anvendt ved andre kirurgiske teknikker end lumbal interkorporal fusion
implanted at locations other than lumbar spine used in surgical techniques other than lumbar interbody fusion

de hyppigste bivirkninger for inductos ved lumbal interkorporal fusionskirurgi var radikulopatiske hændelser og ved akut tibiafrakturkirurgi lokaliseret infektion.
the most common adverse reactions for inductos in lumbar interbody fusion surgery were radiculopathic events, and in acute tibia fracture surgery it was localised infection.

for at undgå overdreven farmakologisk virkning af inductos skal der udvises omhu og forsigtighed for at undgå overfyldning af det lumbale interkorporal fusionsdevice og/eller den anteriore del af det intervertebrale diskusrum.
to avoid exaggerated pharmacological effects of inductos, care and caution should be used to prevent overfilling the lumbar interbody fusion device and/or the anterior portion of the intervertebral disc space.

inductos er indiceret ved enkelniveau lumbal interkorporal spinal fusion som erstatning for autogent knogletransplantat hos voksne med degenerativ diskussygdom, som i mindst 6 måneder er behandlet ikke-operativt for denne sygdom.
inductos is indicated for single-level lumbar interbody spine fusion as a substitute for autogenous bone graft in adults with degenerative disc disease who have had at least 6 months of non-operative treatment for this condition.

histologiske resultater fra dyrestudier af lumbal interkorporal fusion ved anvendelse af anteriore eller posteriore operationsmetoder viste, at dibotermin alfa administreret med titan, peek eller allotransplantat interkorporal devices var biokompatibelt og frembragte konsekvent høje hyppigheder af fusion uafhængigt af operationsmetode eller devicemateriale med mindre synligt fibrøst væv sammenlignet med autotransplantat.
histological evidence from animal studies of lumbar interbody fusion using anterior or posterior surgical approaches showed dibotermin alfa administered with titanium, peek or allograft interbody devices was biocompatible and produced consistently high rates of fusion independent of surgical approach or device material with less fibrous tissue evident compared with autograft.

det nødvendige volumen af inductos bestemmes af det intervertebrale diskusrum og størrelsen, formen og det indre volumen af det/de anvendte lumbale interkorporale fusionsdevice(r).
the required volume of inductos is determined by the intervertebral disc space and the size, shape, and internal volume of the lumbar interbody fusion device(s) being used.